Vascular responses to compound 48/80 in rat mesenteric vascular beds

Honghua Jin, Zhen Li, Shingo Takatori, Toshihiro Koyama, Xin Jin, Yoshito Zamami, Hiromu Kawasaki, Pengyuan Sun

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

A further investigation was performed on the vascular effect of endogenous histamine using the histamine releaser, compound 48/80, in rat mesenteric vascular beds with active tone. In preparations with intact endothelium, low concentrations of compound 48/80 (1.53 × 10−5 – 3 × 1.53 × 10−5 mg/mL) perfusion for 1 min only induced a small vasodilation. High concentrations of compound 48/80 (1.53 × 10−4 – 3 × 1.53 × 10−2 mg/mL) induced a biphasic vascular responses, an initial vasoconstriction followed a subsequent long-lasting vasodilation. The vasodilation induced by low concentrations of compound 48/80 and the vasoconstriction induced by high concentration of compound 48/80 was inhibited by olopatadine. However, cimetidine did not affect the responses induced by compound 48/80. Endothelium removal enlarged the compound 48/80-induced phase-2 vasoconstriction, while it attenuated the phase-3 vasodilation. Additionally, indomethacin and seratrodast significantly inhibited vasoconstriction but it did not affect the long-lasting vasodilation induced by high concentrations of compound 48/80. Ruthenium red inhibited the vasodilation induced by low concentrations and high concentrations of compound 48/80. These results suggest that the vasoconstriction induce by high concentrations of compound 48/80 is mediated by endogenous histamine released from mast cells. It is also suggested that thromboxane A2 released from mast cells is related to the vasoconstriction.

Original languageEnglish
Pages (from-to)620-626
Number of pages7
JournalCanadian Journal of Physiology and Pharmacology
Volume94
Issue number6
DOIs
Publication statusPublished - 2016

Fingerprint

p-Methoxy-N-methylphenethylamine
Blood Vessels
Vasoconstriction
Vasodilation
Histamine
seratrodast
Mast Cells
Endothelium
Ruthenium Red
Thromboxane A2
Cimetidine
Indomethacin
Perfusion

Keywords

  • Compound 48/80
  • Endogenous histamine
  • Master cell
  • Perfusion
  • Rat mesenteric resistance artery
  • Vascular response

ASJC Scopus subject areas

  • Physiology
  • Physiology (medical)
  • Pharmacology

Cite this

Vascular responses to compound 48/80 in rat mesenteric vascular beds. / Jin, Honghua; Li, Zhen; Takatori, Shingo; Koyama, Toshihiro; Jin, Xin; Zamami, Yoshito; Kawasaki, Hiromu; Sun, Pengyuan.

In: Canadian Journal of Physiology and Pharmacology, Vol. 94, No. 6, 2016, p. 620-626.

Research output: Contribution to journalArticle

Jin, Honghua ; Li, Zhen ; Takatori, Shingo ; Koyama, Toshihiro ; Jin, Xin ; Zamami, Yoshito ; Kawasaki, Hiromu ; Sun, Pengyuan. / Vascular responses to compound 48/80 in rat mesenteric vascular beds. In: Canadian Journal of Physiology and Pharmacology. 2016 ; Vol. 94, No. 6. pp. 620-626.
@article{2b6844bc9a86423daef67ae2d0e380f6,
title = "Vascular responses to compound 48/80 in rat mesenteric vascular beds",
abstract = "A further investigation was performed on the vascular effect of endogenous histamine using the histamine releaser, compound 48/80, in rat mesenteric vascular beds with active tone. In preparations with intact endothelium, low concentrations of compound 48/80 (1.53 × 10−5 – 3 × 1.53 × 10−5 mg/mL) perfusion for 1 min only induced a small vasodilation. High concentrations of compound 48/80 (1.53 × 10−4 – 3 × 1.53 × 10−2 mg/mL) induced a biphasic vascular responses, an initial vasoconstriction followed a subsequent long-lasting vasodilation. The vasodilation induced by low concentrations of compound 48/80 and the vasoconstriction induced by high concentration of compound 48/80 was inhibited by olopatadine. However, cimetidine did not affect the responses induced by compound 48/80. Endothelium removal enlarged the compound 48/80-induced phase-2 vasoconstriction, while it attenuated the phase-3 vasodilation. Additionally, indomethacin and seratrodast significantly inhibited vasoconstriction but it did not affect the long-lasting vasodilation induced by high concentrations of compound 48/80. Ruthenium red inhibited the vasodilation induced by low concentrations and high concentrations of compound 48/80. These results suggest that the vasoconstriction induce by high concentrations of compound 48/80 is mediated by endogenous histamine released from mast cells. It is also suggested that thromboxane A2 released from mast cells is related to the vasoconstriction.",
keywords = "Compound 48/80, Endogenous histamine, Master cell, Perfusion, Rat mesenteric resistance artery, Vascular response",
author = "Honghua Jin and Zhen Li and Shingo Takatori and Toshihiro Koyama and Xin Jin and Yoshito Zamami and Hiromu Kawasaki and Pengyuan Sun",
year = "2016",
doi = "10.1139/cjpp-2015-0442",
language = "English",
volume = "94",
pages = "620--626",
journal = "Canadian Journal of Physiology and Pharmacology",
issn = "0008-4212",
publisher = "National Research Council of Canada",
number = "6",

}

TY - JOUR

T1 - Vascular responses to compound 48/80 in rat mesenteric vascular beds

AU - Jin, Honghua

AU - Li, Zhen

AU - Takatori, Shingo

AU - Koyama, Toshihiro

AU - Jin, Xin

AU - Zamami, Yoshito

AU - Kawasaki, Hiromu

AU - Sun, Pengyuan

PY - 2016

Y1 - 2016

N2 - A further investigation was performed on the vascular effect of endogenous histamine using the histamine releaser, compound 48/80, in rat mesenteric vascular beds with active tone. In preparations with intact endothelium, low concentrations of compound 48/80 (1.53 × 10−5 – 3 × 1.53 × 10−5 mg/mL) perfusion for 1 min only induced a small vasodilation. High concentrations of compound 48/80 (1.53 × 10−4 – 3 × 1.53 × 10−2 mg/mL) induced a biphasic vascular responses, an initial vasoconstriction followed a subsequent long-lasting vasodilation. The vasodilation induced by low concentrations of compound 48/80 and the vasoconstriction induced by high concentration of compound 48/80 was inhibited by olopatadine. However, cimetidine did not affect the responses induced by compound 48/80. Endothelium removal enlarged the compound 48/80-induced phase-2 vasoconstriction, while it attenuated the phase-3 vasodilation. Additionally, indomethacin and seratrodast significantly inhibited vasoconstriction but it did not affect the long-lasting vasodilation induced by high concentrations of compound 48/80. Ruthenium red inhibited the vasodilation induced by low concentrations and high concentrations of compound 48/80. These results suggest that the vasoconstriction induce by high concentrations of compound 48/80 is mediated by endogenous histamine released from mast cells. It is also suggested that thromboxane A2 released from mast cells is related to the vasoconstriction.

AB - A further investigation was performed on the vascular effect of endogenous histamine using the histamine releaser, compound 48/80, in rat mesenteric vascular beds with active tone. In preparations with intact endothelium, low concentrations of compound 48/80 (1.53 × 10−5 – 3 × 1.53 × 10−5 mg/mL) perfusion for 1 min only induced a small vasodilation. High concentrations of compound 48/80 (1.53 × 10−4 – 3 × 1.53 × 10−2 mg/mL) induced a biphasic vascular responses, an initial vasoconstriction followed a subsequent long-lasting vasodilation. The vasodilation induced by low concentrations of compound 48/80 and the vasoconstriction induced by high concentration of compound 48/80 was inhibited by olopatadine. However, cimetidine did not affect the responses induced by compound 48/80. Endothelium removal enlarged the compound 48/80-induced phase-2 vasoconstriction, while it attenuated the phase-3 vasodilation. Additionally, indomethacin and seratrodast significantly inhibited vasoconstriction but it did not affect the long-lasting vasodilation induced by high concentrations of compound 48/80. Ruthenium red inhibited the vasodilation induced by low concentrations and high concentrations of compound 48/80. These results suggest that the vasoconstriction induce by high concentrations of compound 48/80 is mediated by endogenous histamine released from mast cells. It is also suggested that thromboxane A2 released from mast cells is related to the vasoconstriction.

KW - Compound 48/80

KW - Endogenous histamine

KW - Master cell

KW - Perfusion

KW - Rat mesenteric resistance artery

KW - Vascular response

UR - http://www.scopus.com/inward/record.url?scp=84970949836&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84970949836&partnerID=8YFLogxK

U2 - 10.1139/cjpp-2015-0442

DO - 10.1139/cjpp-2015-0442

M3 - Article

C2 - 26991394

AN - SCOPUS:84970949836

VL - 94

SP - 620

EP - 626

JO - Canadian Journal of Physiology and Pharmacology

JF - Canadian Journal of Physiology and Pharmacology

SN - 0008-4212

IS - 6

ER -